These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Short Synthetic α-Helical-Forming Peptide Amphiphiles for Fungal Keratitis Treatment In Vivo. Wu H; Liu S; Wiradharma N; Ong ZY; Li Y; Yang YY; Ying JY Adv Healthc Mater; 2017 Mar; 6(6):. PubMed ID: 28081296 [TBL] [Abstract][Full Text] [Related]
9. Small-Molecule Morphogenesis Modulators Enhance the Ability of 14-Helical β-Peptides To Prevent Candida albicans Biofilm Formation. Rodríguez López AL; Lee MR; Wang NB; Dunn KK; Sanchez H; Raman N; Andes DR; Lynn DM; Palecek SP Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31209011 [No Abstract] [Full Text] [Related]
10. In vitro and in vivo activity of a novel antifungal small molecule against Candida infections. Wong SS; Kao RY; Yuen KY; Wang Y; Yang D; Samaranayake LP; Seneviratne CJ PLoS One; 2014; 9(1):e85836. PubMed ID: 24465737 [TBL] [Abstract][Full Text] [Related]
11. A chemical screen identifies structurally diverse metal chelators with activity against the fungal pathogen Fallah S; Duncan D; Reichl KD; Smith MJ; Wang W; Porco JA; Brown LE; Whitesell L; Robbins N; Cowen LE Microbiol Spectr; 2024 Apr; 12(4):e0409523. PubMed ID: 38376363 [No Abstract] [Full Text] [Related]
12. Mechanisms of action of antimicrobial peptides ToAP2 and NDBP-5.7 against Candida albicans planktonic and biofilm cells. do Nascimento Dias J; de Souza Silva C; de Araújo AR; Souza JMT; de Holanda Veloso Júnior PH; Cabral WF; da Glória da Silva M; Eaton P; de Souza de Almeida Leite JR; Nicola AM; Albuquerque P; Silva-Pereira I Sci Rep; 2020 Jun; 10(1):10327. PubMed ID: 32587287 [TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationship studies of ultra-short peptides with potent activities against fluconazole-resistant Candida albicans. Ng SMS; Yap JM; Lau QY; Ng FM; Ong EHQ; Barkham T; Teo JWP; Alfatah M; Kong KW; Hoon S; Arumugam P; Hill J; Brian Chia CS Eur J Med Chem; 2018 Apr; 150():479-490. PubMed ID: 29549835 [TBL] [Abstract][Full Text] [Related]
14. Biochemical characterization of an anti-Candida factor produced by Enterococcus faecalis. Shekh RM; Roy U BMC Microbiol; 2012 Jul; 12():132. PubMed ID: 22759735 [TBL] [Abstract][Full Text] [Related]
15. Riboflavin Targets the Cellular Metabolic and Ribosomal Pathways of Candida albicans Lei J; Huang J; Xin C; Liu F; Zhang J; Xie Y; Mao Y; Chen W; Song Z Microbiol Spectr; 2023 Feb; 11(1):e0380122. PubMed ID: 36625571 [TBL] [Abstract][Full Text] [Related]
16. The Emerging Pathogen Candida auris: Growth Phenotype, Virulence Factors, Activity of Antifungals, and Effect of SCY-078, a Novel Glucan Synthesis Inhibitor, on Growth Morphology and Biofilm Formation. Larkin E; Hager C; Chandra J; Mukherjee PK; Retuerto M; Salem I; Long L; Isham N; Kovanda L; Borroto-Esoda K; Wring S; Angulo D; Ghannoum M Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223375 [No Abstract] [Full Text] [Related]
17. Novel Intravenous Immunoglobulin Therapy for the Prevention and Treatment of Candida auris and Candida albicans Disseminated Candidiasis. Xin H; Rosario-Colon JA; Eberle K mSphere; 2023 Feb; 8(1):e0058422. PubMed ID: 36688668 [TBL] [Abstract][Full Text] [Related]
18. Identification of a Phenylthiazole Small Molecule with Dual Antifungal and Antibiofilm Activity Against Candida albicans and Candida auris. Mohammad H; Eldesouky HE; Hazbun T; Mayhoub AS; Seleem MN Sci Rep; 2019 Dec; 9(1):18941. PubMed ID: 31831822 [TBL] [Abstract][Full Text] [Related]
19. Biochemical Characterization of Recombinant Fong JL; Ong Eng Yong V; Yeo C; Adamson C; Li L; Zhang D; Qiao Y ACS Infect Dis; 2024 Sep; 10(9):3408-3418. PubMed ID: 39137394 [No Abstract] [Full Text] [Related]